Showing results (981-990 of 1,355) with videos related to
Sort By:
Pageof 136
Antimicrobial Agents and Chemotherapy|January 30, 2008
Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitroIsabelle Malet, Olivier Delelis, Marc-Antoine Valantin, et al.Plos One|February 3, 2017
Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort studyLaurent Cotte, Tristan Ferry, Pascal Pugliese, et al.Journal of Geriatric Oncology|January 29, 2023
The 10-month mortality rate among older patients treated for digestive system cancer during the first wave of the COVID-19 pandemic: The CADIGCOVAGE multicentre cohort studyThomas Aparicio, Richard Layese, François Hemery, et al.Revue Medicale Suisse|April 20, 2012
[Multispectral bioimpedance and sarcopenia in the elderly]Etienne Rivier, Thierry Gauthier, Marc-Antoine Krieg, et al.Chemical Science|March 21, 2022
Enhancing proline-rich antimicrobial peptide action by homodimerization: influence of bifunctional linkerWenyi Li, Feng Lin, Andrew Hung, et al.International Journal of Molecular Sciences|April 9, 2020
Immunotherapy in Renal Cell Carcinoma: The Future Is NowAntoine Deleuze, Judikaël Saout, Frédéric Dugay, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2022
Birth Country Influences the Choice of Antiretroviral Therapy in HIV-Infected Individuals: Experience From a French HIV CentreRomain Palich, Rachid Agher, Dimoke J Wetshikoy, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 20, 2024
Evidence for secondary ciliary dyskinesia in patients with cystic fibrosisRomane Bonhiver, Noemie Bricmont, Maud Pirotte, et al.Cancer Immunology Research|July 9, 2026
BET inhibition synergizes with RLR signaling to enhance tumor immunogenicity and T cell recognitionLucas Baldran-Groves, Rok Žiberna, Marc-Antoine Gerault, et al.Plos One|October 22, 2015
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected PatientsIsabelle Poizot-Martin, Alissa Naqvi, Véronique Obry-Roguet, et al.Pageof 136